Teva Doubles Production as Japanese Change Attitude to Generics
Teva: Definitely Undervalued (NYSE:TEVA) | Seeking Alpha
/cloudfront-us-east-2.images.arcpublishing.com/reuters/ELYBYTG4QZMUJPXRYDKAVNSTAI.jpg "New branded drugs helping Teva Pharm move closer to growth | Reuters")
New branded drugs helping Teva Pharm move closer to growth | Reuters
Teva Pharmaceutical, Owner of Frazer's Cephalon, Forms Joint Venture With Japanese Drug Firm
Teva recalls seizure drug | Fierce Pharma
Teva Seeking FDA OK to Make Generic of Firdapse for LEMS | But Therapy Maker Catalyst Vows to Enforce Its Property Rights | Lambert-Eaton News
Teva-Takeda joint venture divests certain assets in Japan to Nichi-Iko - Pharmaceutical Technology
Teva Pharmaceuticals USA, Inc. news and information | American Pharmacy News
Teva's Adderall Shortage Expected to Continue Into March, FDA Says - BNN Bloomberg
FDA cites 'significant' sterility concern at Teva injectables plant | Fierce Pharma
ADDING MULTIMEDIA Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™ (albuterol sulfate 117 mcg) Inhalation Powder | Business Wire
Teva changes course in Japan and the US
FDA News Roundup Teva AstraZeneca Amgen Medicines Company And More
TEVA | Market Realist
Teva files potential blockbuster migraine drug for FDA approval
Teva subsidiary opens $100m manufacturing facility in Croatia
Teva's Two Pivotal Studies on Ajovy in Japan Meet Goal
Meet The New Teva: 8% Global Generics Share, 300 ANDAs, 1,500 Launches :: Scrip
Alvotech and Teva Announce Acceptance of U.S. Biologics License Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab)
Teva's Key Drugs in Its Specialty Products Pipeline
US FDA accepts Teva-MedinCell's NDA for drug to treat schizophrenia
Teva reports positive Phase III migraine trial - Globes
Teva Analysts Say Migraine Drug Approval Gives Needed Relief - Bloomberg
Teva Pursues Regulatory Approval in Japan for MS Drug Copaxone
Teva faces US marketing investigation - PMLiVE
Generic EpiPen by Teva Wins FDA Nod After 2 Year Delay | Fierce Pharma
FDA Approves Teva's Generic Version of EpiPen Injector - WSJ
